viewOpen Orphan PLC

Open Orphan merger with hVIVO declared unconditional

The deal has been accepted by shareholders owning 86.9% of the hVIVO shares

Open Orphan PLC -

The merger between Open Orphan PLC (LON:ORPH) and AIM-listed peer hVIVO PLC (LON:HVO) is going ahead after sufficient shareholder approval has been received. 

So far, the deal, where hVIVO shareholders will receive 2.47 Open Orphan shares for every hVIVO share they own, has gained acceptance over 86.9% of the hVIVO shares.

READ: Open Orphan and hVIVO to merge

As a result, the Open Orphan board has lowered the acceptance condition to 75%, meaning that the acceptance condition has been satisfied and the offer has become unconditional as to acceptances.

Cathal Friel, chief executive of Open Orphan said: “We are pleased with the strong level of acceptances which reinforces our view that this is a good deal for the shareholders of both companies. 

“The merger will allow the combined business to maximise shareholder value as we seek to build a larger-scale, profitable, specialist pharma services business.”

Quick facts: Open Orphan PLC

Price: 5.9 GBX

Market: AIM
Market Cap: £32.39 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...



Open Orphan catching global attention with 'stunning' FLU-v results &...

Open Orphan PLC's (LON:ORPH) Cathal Friel and its subsidiary hVIVO's chief scientist Dr Andrew Catchpole sat down with Proactive London's Andrew Scott. This morning Open Orphan announced the results from a clinical trial of a broad-spectrum flu jab that they're jointly developing have been...

3 weeks, 3 days ago

2 min read